SCHEMBL6014544

SCHEMBL6014544

CCCCNS(=O)(=O)c1ccc(-c2ncc(-c3ccc(N(C)C)cc3)o2)cc1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.47
LMNA P02545 4/20 0.43
HTT P42858 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MMP2 P08253 3/20 0.42
MMP9 P14780 3/20 0.42
CA2 P00918 2/20 0.42
CA1 P00915 1/20 0.42
TP53 P04637 4/20 0.41
MAPT P10636 2/20 0.41
ALOX15 P16050 2/20 0.40
CASP1 P29466 2/20 0.40
NPC1 O15118 1/20 0.40
POLB P06746 1/20 0.39
CA9 Q16790 2/20 0.38
ADORA2B P29275 1/20 0.38
CA12 O43570 1/20 0.38
KMT2A Q03164 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6014405 0.88 HTR6 (0.48) HTR6LMNAMMP2MMP9CA2
SCHEMBL6014471 0.84 HTR6 (0.48) HTR6POLBKMT2A
SCHEMBL6014472 0.83 MMP2 (0.47) HTR6LMNASMN1; SMN2MMP2MMP9
SCHEMBL6014355 0.83 MMP9 (0.48) HTR6LMNASMN1; SMN2MMP2MMP9
SCHEMBL6014370 0.83 HTR6 (0.50) HTR6LMNASMN1; SMN2TP53MAPT
SCHEMBL6014512 0.83 HTR6 (0.44) HTR6LMNASMN1; SMN2MMP2MMP9
SCHEMBL300386 0.82 HTR6 (0.44) HTR6LMNAMMP2MMP9CA2
SCHEMBL13550996 0.81 HTR6 (0.42) HTR6LMNAMMP2MMP9CA2
SCHEMBL6014500 0.80 MMP2 (0.43) HTR6LMNASMN1; SMN2MMP2MMP9
SCHEMBL6014557 0.80 HTR6 (0.42) HTR6LMNAMMP2MMP9CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7078406-B2 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT, L.L.C. (US) 2006-07-18 US disclosed
US-20040248851-A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes Life Technologies Corporation 2004-12-09 US disclosed
US-6815445-B2 FOR USE AS FLUORESCENCE DYES AND PROBES Life Technologies Corporation 2004-11-09 US disclosed
US-20030105111-A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes 3-DIMENSIONAL PHARMACEUTICALS, INC. 2003-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040248851-A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes DHFR, FPR1, CYP1A1 HTR6 1602/4885LMNA 1981/4885HTT 3925/4885
US-20030105111-A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes DHFR, FPR1, CYP1A1 HTR6 1602/4885LMNA 1981/4885HTT 3925/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.